
Results
6
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
6 companies
B-SOFTLtd
Market Cap: CN¥5.5b
Operates in the healthcare information technology industry in China.
300451
CN¥3.55
7D
-4.3%
1Y
-33.3%
Dian Diagnostics GroupLtd
Market Cap: CN¥12.1b
Provides integrated medical diagnostics solutions with independent diagnostic services in China.
300244
CN¥19.79
7D
17.7%
1Y
31.0%
Lepu Medical Technology (Beijing)
Market Cap: CN¥21.7b
Engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally.
300003
CN¥11.75
7D
-3.4%
1Y
-8.1%
Truking Technology
Market Cap: CN¥5.7b
Engages in medical equipment business in China and internationally.
300358
CN¥7.92
7D
-3.9%
1Y
7.5%
Shenzhen Bioeasy Biotechnology
Market Cap: CN¥2.6b
Provides rapid food testing reagents and instruments in China and internationally.
300942
CN¥6.39
7D
-1.1%
1Y
-31.4%
Cowealth Medical ChinaLtd
Market Cap: CN¥4.8b
Operates as a medical company in China.
603122
CN¥12.12
7D
-2.6%
1Y
81.7%